CTBO (Cantabio Pharmaceuticals) Book Value per Share: $-99.42 (As of Dec. 2018)


What is Cantabio Pharmaceuticals Book Value per Share?

Cantabio Pharmaceuticals CTBO Book Value per Share is $-99.42 as of Dec. 2018.

Cantabio Pharmaceuticals's book value per share for the quarter that ended in Dec. 2018 was $-99.42.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

Cantabio Pharmaceuticals's current price is $1.01. Its book value per share for the quarter that ended in Dec. 2018 was $-99.42. Hence, today's PB Ratio of Cantabio Pharmaceuticals is .

Cantabio Pharmaceuticals  (OTCPK:CTBO) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Cantabio Pharmaceuticals Book Value per Share Related Terms

Cantabio Pharmaceuticals Book Value per Share Historical Data

* Premium members only.

The historical data trend for Cantabio Pharmaceuticals's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantabio Pharmaceuticals Book Value per Share Chart

Cantabio Pharmaceuticals Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Book Value per Share
Get a 7-Day Free Trial -0.40 -43.60 -74.00 -170.80 -187.30

Cantabio Pharmaceuticals Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -300.00 -187.30 -209.36 -151.44 -99.42

CTBO vs TNTY, ETNI, NTRR: Book Value per Share Comparison

For the Biotechnology subindustry, Cantabio Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cantabio Pharmaceuticals PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cantabio Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Cantabio Pharmaceuticals's PB Ratio falls into.


Cantabio Pharmaceuticals Book Value per Share Calculation

Cantabio Pharmaceuticals's Book Value Per Share for the fiscal year that ended in Mar. 2018 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-1.87-0.00)/0.01
=-187.30

Cantabio Pharmaceuticals's Book Value Per Share for the quarter that ended in Dec. 2018 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-1.89-0.00)/0.02
=-99.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Frequently Asked Questions Learn more about Book Value per Share →
What does a Book Value per Share of $-99.42 mean?
Cantabio Pharmaceuticals (CTBO) has a Book Value per Share of $-99.42 as of Dec. 2018. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Cantabio Pharmaceuticals and its competitors.
Is Cantabio Pharmaceuticals' Book Value per Share too high?
Cantabio Pharmaceuticals' current Book Value per Share is $-99.42.
How does Cantabio Pharmaceuticals' Book Value per Share compare to TNTY and ETNI?
Cantabio Pharmaceuticals' Book Value per Share of $-99.42 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Biotechnology company?
A good Book Value per Share depends on the Biotechnology industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Cantabio Pharmaceuticals and its competitors. Cantabio Pharmaceuticals's current Book Value per Share is $-99.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantabio Pharmaceuticals stock overvalued right now?
Cantabio Pharmaceuticals (CTBO) has a current Book Value per Share of $-99.42. The current Book Value per Share is $-99.42. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Cantabio Pharmaceuticals (CTBO), the current Book Value per Share is $-99.42 as of Dec. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantabio Pharmaceuticals Business Description

Address 1250 Oakmead Parkway, Sunnyvale, CA, USA, 94085
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.